Thorac Surg Clin 23(4):ix-x, 2013
135, 266, 934, 938, 942 Szwarc, P
Your provider should confirm storage capacity and access before prescribing
There have been several cardiovascular outcomes trials (CVOTs) involving GLP-1RAs, which have supported the overall cardiovascular benefits of these drugs
These improvements include: Gastrointestinal Benefits: Reduced chronic diarrhea and abdominal cramping Improved tolerance to previously triggering foods Decreased bloating and digestive discomfort Better overall gut stability Systemic Improvements: Reduction in chronic fatigue and brain fog Decreased frequency and severity of flushing episodes Improved sleep quality and energy levels Better exercise tolerance without triggering flares Skin and Respiratory Changes: Fewer spontaneous hives and skin reactions Reduced respiratory symptoms and wheezing Less reactive responses to environmental triggers Improved overall symptom stability What particularly strikes me is the timing of these improvements
PlexusDx also offers GLP-Squared injection, which combines semaglutide and tirzepatide to activate multiple appetite and metabolic pathways simultaneously
